site stats

Glendon french pulmonx

WebOct 23, 2024 · Oct 23, 2024. President and CEO of Pulmonx Corp ( 30-Year Financial, Insider Trades) Glendon E. French Iii ( insider trades) sold 25,000 shares of LUNG on 10/21/2024 at an average price of $39.75 a share. The total sale was $993,750. WebGlendon E French is President/CEO at Asthmatx Inc. See Glendon E French's compensation, career history, education, & memberships.

Glendon E. French - President & CEO at Pulmonx The Org

WebApr 10, 2024 · In other Pulmonx news, CEO Glendon E. French III sold 2,895 shares of the firm's stock in a transaction that occurred on Wednesday, March 1st. The stock was sold at an average price of $11.03, for a total value of $31,931.85. Following the sale, the chief executive officer now directly owns 1,032,580 shares of the company's stock, valued at ... WebNov 18, 2024 · Glendon French is a President/CEO at Pulmonx and Board Member at Pulmonx. He has worked as Board Member at Cardiac Pathways Corp, Board Member … batting injury https://ishinemarine.com

Glendon E French, Pulmonx Corp: Profile and Biography

WebMar 5, 2024 · Pulmonx aims to raise $86 million in a U.S. IPO, although the final figure may differ. ... Management is headed by President and CEO Glendon French, who has been with the firm since 2014 and was ... WebMay 7, 2024 · Joining me from Pulmonx are Glendon French, President and Chief Executive Officer; and Derrick Sung, Chief Financial Officer. Earlier today, Pulmonx … WebPulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. … tibet budizam okean asocijacije

President And CEO Of Pulmonx Sold $1.85 Million In Stock

Category:Pulmonx Company Profile - Office Locations, Competitors ... - Craft

Tags:Glendon french pulmonx

Glendon french pulmonx

Pulmonx Co. (NASDAQ:LUNG) Receives Average Rating of …

WebNov 30, 2024 · “We are excited about this approval and the opportunity to enable the Japanese medical community to bring a much-needed treatment option to patients with severe COPD/emphysema,” stated Glendon French, President and Chief Executive Officer of Pulmonx. “Japan is the second largest healthcare market in the world and represents … WebSep 16, 2024 · Mr French LUNG stock SEC Form 4 insiders trading. Mr has made over 20 trades of the Pulmonx Corp stock since 2024, according to the Form 4 filled with the SEC. Most recently he sold 3,631 units of LUNG stock worth $21,532 on 1 December 2024.. The largest trade he's ever made was selling 50,000 units of Pulmonx Corp stock on 18 …

Glendon french pulmonx

Did you know?

WebNov 30, 2024 · Pulmonx Receives Japanese MHLW Approval of Zephyr Endobronchial Valve for the Treatment of Severe COPD/Emphysema WebMar 1, 2024 · CEO of Pulmonx Glendon E. French has served as our President, Chief Executive Officer and as a member of our board of directors since December 2014. From …

WebPULMONX CORPORATION: By: /s/Glendon E. French: Glendon E. French: President, Chief Executive Officer and Director: Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement or amendment thereto has been signed by the following persons in the capacities and on the dates indicated. WebSep 24, 2024 · Management is headed by President and CEO Glendon French, who has been with the firm since 2014 and was previously CEO and director at ApniCure, a medical device firm. Below is a brief overview ...

WebFeb 28, 2024 · Medical device giant Boston Scientific Corp. (NYSE: BSX) owns 30% of Pulmonx, which is led by President and CEO Glendon French. Other investors include Bay Area venture capital firms Kleiner ... WebMar 3, 2024 · Joining me from Pulmonx are Glenn French, President and Chief Executive Officer; and Derrick Sung, Chief Financial Officer. Earlier today, Pulmonx released …

WebPULMONX CORPORATION: By: /s/Glendon E. French: Glendon E. French: President, Chief Executive Officer and Director: Pursuant to the requirements of the Securities Act of 1933, as amended, this registration statement or amendment thereto has been signed by the following persons in the capacities and on the dates indicated.

WebDec 5, 2024 · As President and CEO of Pulmonx Corp, Glendon E. French has a total base salary of $442,803 . Glendon E. French received compensation valued at about … tibetanska gljiva nuspojaveWebGlendon E French, Pulmonx Corp: Profile and Biography - Bloomberg Markets Bloomberg Bloomberg Anywhere Remote Login Software Updates Manage Products and Account … batting lineup templateWebApr 6, 2024 · Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. ... Glendon E French MBA ... batting helmet padding kitWebApr 13, 2024 · The company’s quarterly revenue was up 12.4% on a year-over-year basis. As a group, sell-side analysts expect that Pulmonx will post -1.75 EPS for the current year. Insider Activity. In other news, CEO Glendon E. French III sold 2,895 shares of the business’s stock in a transaction on Wednesday, March 1st. The shares were sold at an … tibet glavni gradWebFind company research, competitor information, contact details & financial data for Pulmonx Corporation of Redwood City, CA. Get the latest business insights from Dun & Bradstreet. D&B Business Directory HOME / BUSINESS DIRECTORY / ... Glendon E French. President and Chief Executive Officer. batting material near meWebFrench served as the Executive Chairman of the board of directors of Levita Magnetics International Corp., a medical device company, from August 2013 to January 2024. Mr. … tibet državaWebPulmonx's President & CEO is Glendon E. French. Other executives include Beran Rose, Chief Commercial Officer; Sri Radhakrishnan, Chief Technical Officer and 12 others. See the full leadership team at Craft. batting machine baseball